Author of the publication

Decreased P-glycoprotein function at the blood-brain barrier in patients with Alzheimer's disease as shown by (R)-11Cverapamil and PET.

, , , , , , , , , and . NeuroImage, 52 (Supplement-1): S53 (2010)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Microglial activation in healthy aging., , , , , , , , , and 1 other author(s). NeuroImage, 52 (Supplement-1): S32 (2010)Hippocampal shape analysis in Alzheimer's disease: A population-based study., , , , , , , , , and 1 other author(s). NeuroImage, 36 (1): 8-18 (2007)Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior., , , , , , and . NeuroImage, 25 (1): 63-75 (2005)The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease., , , , , , , , , and . Brain Connect., 6 (1): 1-8 (2016)Disruption of Functional Brain Networks in Alzheimer's Disease: What Can We Learn from Graph Spectral Analysis of Resting-State Magnetoencephalography?, , , , , and . Brain Connect., 2 (2): 45-55 (2012)A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry., , , , , , , , , and . NeuroImage, 18 (4): 895-907 (2003)Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRI., , , , , , , and . NeuroImage, 21 (1): 173-180 (2004)Corrigendum to "Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer's disease" Neuroimage 66 (2013) 28-35., , , , , , , , and . NeuroImage, (2013)Virtual neural network-guided optimization of non-invasive brain stimulation in Alzheimer's disease., , , and . PLoS Comput. Biol., (January 2024)Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease., , , , and . NeuroImage, 26 (4): 1078-1085 (2005)